NRD
EXAS

Nebula Research & Development’s Exact Sciences EXAS Stock Holding History

Nebula Research & Development’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,006
Closed -$693K – 1012
2025
Q1 		$693K Sell
16,006
-42,433
-73% -$2.15M 0.06% 498
2024
Q4 		$3.28M Buy
+58,439
New +$3.64M 0.39% 32
2024
Q3 		– Sell
-10,328
Closed -$436K – 1001
2024
Q2 		$436K Buy
+10,328
New +$568K 0.07% 476
2023
Q2 		– Sell
-3,392
Closed -$230K – 372
2023
Q1 		$230K Buy
+3,392
New +$218K 0.41% 152

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Nebula Research & Development's EXAS Position: Q2 2025 in Review

Nebula Research & Development sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 16,006 shares — an estimated $693K sold.

Nebula Research & Development first reported a position in EXAS in Q1 2023 and held it in 4 quarters. The position peaked at $3.28M in Q4 2024. 558 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Nebula Research & Development reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Nebula Research & Development sold 16,006 Exact Sciences shares in Q2 2025, an estimated $693K.
  • Nebula Research & Development first reported a position in Exact Sciences in Q1 2023 and held it in 4 quarters.
  • Nebula Research & Development's Exact Sciences position peaked at $3.28M in Q4 2024.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Nebula Research & Development's 13F filing for Q2 2025, filed 14 Aug 2025.